The Women's Bible Study classes will resume on Sept. 16. There are two classes to choose from every Tuesday -- 9:15-11:15 a.m ...

NiKang Therapeutics® Inc. ("NiKang"), a clinical stage biotech company focused on developing innovative small molecule ...

Former male high-level rugby players in New Zealand have a 22% increased risk of developing Alzheimer's and other dementias ...

Absci is developing ABS-101, an anti-TL1A antibody with potential in ulcerative colitis, Crohn's disease, and other ...

Sacubitril/valsartan shows evidence of benefit in the first randomized trial evaluating a drug treatment for patients with ...

Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profile ...

Case-based questions in Accountancy typically present a hypothetical business situation or a real-world accounting dilemma.

Rapport Therapeutics, Inc.'s RAP-219 shows strong Phase 2a results for drug-resistant seizures, boosting stock and optimism.

A new study has found "strong causal evidence" that banning phones improves results in the classroom - and a local principal ...

In a milestone for Southeast Asia's healthcare sector, Singapore's Ministry of Health (MOH), MOH Holdings Pte Ltd (MOHH), and the Centre for ...

RTX001 is the first engineered Regenerative Macrophage Therapy (RMT) to be evaluated in humans with advanced liver fibrosisFirst patient has successfully cleared safety period with no serious adverse ...

There could be a 90 percent chance that in the next decade, astronomers will spot a deep space explosion that confirms ...